Options Brief: Onyx Pharmaceuticals

Shares of Onyx Pharmaceuticals ONXX are higher on the session by 2.86%, trading at $33.42. Overall call volume is now running at 2.13x the daily average, with 7% of all calls traded being purchases on the offer. 1,787 contracts have traded on the session so far. Onyx Pharmaceuticals, Inc. is a biopharmaceutical company engaged in developing therapies that target the molecular mechanisms that cause cancer. With the company's collaborator, Bayer HealthCare Pharmaceuticals, the company is developing and commercializing anticancer therapies.